A comparative study of the effects of vitamin C, sirolimus, and paclitaxel on the growth of endothelial and smooth muscle cells for cardiovascular medical device applications

Drug Design, Development and Therapy

Volumn 7, Issue , 2013, Pages 529-544

  Kakade, Sandeep ^a   Mani, Gopinath ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Cardiovascular; Drug eluting stents; Endothelial cells; Stents; Thrombosis

Indexed keywords

ASCORBIC ACID; PACLITAXEL; RAPAMYCIN; CD31 ANTIGEN;

ARTICLE; CARDIOVASCULAR EQUIPMENT; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; SMOOTH MUSCLE FIBER; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; PHENOTYPE; PHYSIOLOGY;

ANTIGENS, CD31; ASCORBIC ACID; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; MYOCYTES, SMOOTH MUSCLE; PACLITAXEL; PHENOTYPE; SIROLIMUS;

EID: 84879582297     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S45162     Document Type: Article

References (35)

1. Mani G, Feldman MD, Patel D, Agrawal CM. Coronary stents: a materials perspective. Biomaterials. 2007;28(9):1689-1710.
2. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater. 2005;74(1):570-581.
3. Ratner BD. The catastrophe revisited: blood compatibility in the 21st Century. Biomaterials. 2007;28(34):5144-5147.
4. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med. 1996;47:315-331.
5. Werner C, Maitz MF, Sperling C. Current strategies towards hemocompatible coatings. J Mater Chem. 2007;17:3376-3384.
6. Kapadia MR, Popowich DA, Kibbe MR. Modified prosthetic vascular conduits. Circulation. 2008;117(14):1873-1882.
7. Garg S, Serruys PW. Coronary stents current status. J Am Coll Cardiol. 2010;56(10):S1-S42.
8. Kipshidze N, Dangas G, Tsapenko M, et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004;44(4):733-739.
9. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190:300-309.
10. Joner M, Nakazawa G, Finn AV, etal. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52(5):333-342.
11. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27(7):1500-1510.
12. Pilgrim T, Windecker S. Drug-eluting stent thrombosis. Minerva Cardioangiol. 2009;57(5):611-620.
13. Innocente F, Mandracchia D, Pektok E, etal. Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? Circulation. 2009;120(Suppl 11):S37-S45.
14. Baek I, Bai CZ, Hwang J, Nam HY, Park JS, Kim DJ. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia. J Vasc Surg. 2012;55(3):806-814.
15. Aguirre R, May JM. Inflammation in the vascular bed: importance of vitamin C. Pharmacol Ther. 2008;119:96-103.
16. Farbstein D, Kozak-Blickstein A, Levy AP. Antioxidant vitamins and their use in preventing cardiovascular disease. Molecules. 2010;15:8098-8110.
17. Ma Z, Kotaki M, Yong T, He W, Ramakrishna S. Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials. 2005;26(15):2527-2536.
18. Granchi D, Cenni E, Verri E, etal. Adhesive protein expression on human endothelial cells after in vitro contact with woven Dacron. Biomaterials. 1998;19(1-3):93-98.
19. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol. 1991;114(5):1059-1068.
20. Marx S, Jayaraman T, Go L, Marks A. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circulation Research. 1995;76(3):412-417.
21. Axel DI, Kunert W, Göggelmann C, etal. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96(2):636-645.
22. Ulrich-Merzenich G, Zeitler H, Panek D, Bokemeyer D, Vetter H. Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway. Eur J Nutr. 2007;46(2):87-94.
23. Ulrich-Merzenich G, Metzner C, Schiermeyer B, Vetter H. Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Eur J Nutr. 2002;41:27-34.
24. Smith AR, Visioli F, Hagen TM. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J. 2002;16(9):1102-1104.
25. Siow RC, Sato H, Leake DS, Pearson JD, Bannai S, Mann GE. Vitamin C protects human arterial smooth muscle cells against atherogenic lipoproteins: effects of antioxidant vitamins C and E on oxidized LDL-induced adaptive increases in cystine transport and glutathione. Arterioscler Thromb Vasc Biol. 1998;18:1662-1670.
26. Libby P, Aikawa M. Vitamin C, collagen, and cracks in the plaque. Circulation. 2002;105:1396-1398.
27. Rossig L, Hoffmann J, Hugel B, Mallat Z, Hasse A, Freyssinet JM. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation. 2001;104:2182-2187.
28. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem. 2001;276:40-47.
29. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95(12):2617-2622.
30. Gocke N, Keaney JF, Frei B, etal. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999;99:3234-3240.
31. Lu LH, Lee YT, Chen HW, Chiang LY, Huang HC. The possible mechanisms of the antiproliferative effect of fullerenol, polyhydroxylated C60, on vascular smooth muscle cells. Br J Pharmacol. 1998;123(6): 1097-1102.
32. Bordia A, Verma SK. Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients. Clin Cardiol. 1985;8:552-554.
33. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol. 2006;47(10):2112-2115.
34. Levine M, Dhariwal KR, Welch RW, Wang Y, JB. P. Determination of optimal vitamin C requirements in humans. Am J Clin Nutr. 1995;62(Suppl 6):1347S-1356S.
35. Bowie AG, O'Neill LA. Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38mitogen-activated protein kinase. J Immunol. 2000;165(12):7180-7188.